Solifenacin (INN, trade name Vesicare) is a medicine of the antimuscarinic class and was developed for treating contraction of overactive bladder with associated problems such as increased urination frequency and urge incontinence. It is manufactured and marketed by Astellas, GlaxoSmithKline and Teva Pharmaceutical Industries.

CAS：242478-37-1
中文别名：索利那新;1-氮杂双环[2.2.2]辛烷-8-基-(1S)-1-苯基-3,4-二氢-1H-异喹啉-2-甲酸酯;
英文别名：3,4-dihydro-1-phenyl-(1S)-2(1H)-Isoquinolinecarboxylic acid (3R)-1-azabicyclo[2.2.2]oct-3-yl ester;2(1H)-Isoquinolinecarboxylic acid,3,4-dihydro-1-phenyl-,1-azabicyclo(2.2.2)oct-3-yl ester,(R-(R*,S*));(1S)-1-phenyl-1,2,3,4-tetrahydroisoquinoline-2-carboxylate;(1S)-(3R)-1-azabicyclo[2,2,2]oct-3-yl-3,4-dihydro-1-phenyl-2(1H)-isoquinoline carboxylate;(1S,3\'R)-quinuclidin-3\'-yl 1-phenyl-1,2,3,4-tetrahydroisoquinoline-2-carboxylate;Unii-A8910sqj1u;(+)-solifenacin;(1S)-3,4-dihydro-1-phenyl-2(1H)-isoquinolinecarboxylic acid (3R)-1-azabicyclo[2.2.2]oct-3-yl ester;YM 905;(3R)-1-azabicyclo[2.2.2]oct-3-yl (1S)-3,4-dihydro-1-phenyl-2(1H)-isoquinolinecarboxylate;[(8R)-1-azabicyclo[2.2.2]octan-8-yl] (1S)-1-phenyl-3,4-dihydro-1H-isoquinoline-2-carboxylate;
分子式：C23H26N2O2
分子量：362.465
精确质量：362.199
Psa：32.78
Logp：3.7407

UNII：A8910SQJ1U

密度：1.24g/cm3
沸点：505.5ºC at 760 mmHg
闪点：259.5ºC
折射率：1.648
蒸汽压：2.41E-10mmHg at 25°C